Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank25
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-9.57
Near historical average
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthNormalizing
Average
-8.91
Historical baseline
PeriodValueYoY Change
2025-9.57+68.1%
2024-29.96-604.6%
2023-4.25-42.6%
2022-2.98+61.5%
2021-7.74-84.6%
2020-4.19+8.1%
2019-4.56+35.0%
2018-7.02+29.5%
2017-9.96-